Log in to search using one of your social media accounts:

 

Laminate Medical launches study of VasQ hemodialysis fistula device
Laminate Medical Technologies said today it launched a pivotal, FDA-cleared trial of its VasQ implanted blood vessel device designed for patients requiring arteriovenous fistulas as vascular access for hemodialysis. The Israel-based company’s VasQ device is designed to aid kidney failure patients in need of dialysis by providing external support to reduce fistula failure. The device regulates flow by constraining and shaping the fistula and reinforces and shields the perianastomotic vein against high pressure, wall tension and flow levels, the company said. The first procedures in the trial were recently perform...
Source: Mass Device - January 19, 2018 Category: Medical Devices Authors: Fink Densford Tags: Blood Management Clinical Trials Vascular Laminate Medical Technologies Source Type: news

Groups Condemn U.S. Cuts to Palestinian Refugee Agency
Displaced children in a UN-run school in the Shujaiyeh neighbourhood of Gaza.Credit: Khaled Alashqar/IPSBy Tharanga YakupitiyageUNITED NATIONS, Jan 19 2018 (IPS)International organizations have criticized the United States’ decision to cut more than half of planned funding to a UN agency serving Palestinian refugees. This week, the U.S. administration announced that it is withholding 65 million dollars from a planned 125-million-dollar aid package for the UN Relief and Works Agency for Palestinian Refugees (UNRWA).UNRWA serves over 5 million refugees with education, healthcare, social services, and emergency assistan...
Source: IPS Inter Press Service - Health - January 19, 2018 Category: International Medicine & Public Health Authors: Tharanga Yakupitiyage Tags: Aid Armed Conflicts Crime & Justice Education Headlines Health Human Rights IPS UN: Inside the Glasshouse Middle East & North Africa Migration & Refugees TerraViva United Nations Source Type: news

Length of opioid prescription spell highest risk for misuse after surgery
(Beth Israel Deaconess Medical Center) With opioid overdoses now a leading cause of nonintentional death in the United States, data show most of these deaths can be traced back to an initial prescription opioid. A new study led by investigators at Beth Israel Deaconess Medical Center (BIDMC) and Harvard Medical School (HMS) sheds light on the possible link between physicians' opioid prescription patterns and subsequent abuse. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 19, 2018 Category: International Medicine & Public Health Source Type: news

Wastewater Treatment Plants in Rapid Mass Displacement Situations
Governance and Social Development Resource Centre. 11/07/2017 This 15-page rapid review report has identified the wastewater treatment plant options used in emergency settings, with decentralized wastewater treatment systems and mobile wastewater treatment units performing most effectively and with minimal costs. Examples are taken from refugee camps and internally displaced people settlements due to the Iraq war, the Israeli-Palestine conflict, and the civil wars in Syria and Sudan. (PDF) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - January 19, 2018 Category: International Medicine & Public Health Authors: The U.S. National Library of Medicine Source Type: news

Teva cutting 200+ local jobs as part of broader restructuring plan
Teva Pharmaceutical Industries will be laying off more than 200 local employees as part of a major restructuring plan designed to save the company $3 billion by the end of 2019. The Israeli generic drug maker, which calls North Wales, Pa. its U.S. headquarters, said last month it would eliminate 14,000 positions globally — more that 25 percent of its total work force — over the next two years. It has about 56,000 employees worldwide including about 2,000 people in Nor th Wales, West Chester and… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - January 18, 2018 Category: Biotechnology Authors: Jeff Blumenthal Source Type: news

EOS Imaging 2017 sales up by 21%
Citing growth in Europe, the Middle East, and Africa (EMEA) and Asia-Pacific...Read more on AuntMinnie.comRelated Reading: EOS debuts new spinal surgery planning software EOS Imaging makes executive moves EOS installs 1st systems in China EOS Imaging revenue grows in Q1 EOS Imaging makes 1st Israeli sale (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 17, 2018 Category: Radiology Source Type: news

Obese patients lived longer if they had weight loss surgery, study finds
Bariatric surgery has become the medical profession ’s go-to solution for meaningful weight loss, and new research shows why: It saves lives.In a retrospectivestudy of close to 34,000 Israeli patients with obesity, the 8,385 who got one of three surgical procedures were roughly two times less... (Source: Los Angeles Times - Science)
Source: Los Angeles Times - Science - January 17, 2018 Category: Science Authors: Melissa Healy Source Type: news

High-Fat Diet May Fuel Spread of Prostate Cancer
New research suggests a strong link between genes, dietary fat and prostate cancer. (Source: NYT Health)
Source: NYT Health - January 16, 2018 Category: Consumer Health News Authors: GINA KOLATA Tags: Prostate Cancer Obesity Prostate Gland Diet and Nutrition Genetics and Heredity Mice Tumors Beth Israel Deaconess Medical Center Nature Genetics (Journal) Source Type: news

Fatty Western diets make prostate cancer more aggressive
Researchers at Harvard and Beth Israel have made a 'breakthrough' discovery about how prostate cancer is fueled. (Source: the Mail online | Health)
Source: the Mail online | Health - January 15, 2018 Category: Consumer Health News Source Type: news

Dietary fat, changes in fat metabolism may promote prostate cancer metastasis
(Beth Israel Deaconess Medical Center) Researchers at the Cancer Center at Beth Israel Deaconess Medical Center (BIDMC) shed new light on the genetic mechanisms that promote metastasis in the mouse model and also implicated the typical Western high-fat diet as a key environmental factor driving metastasis. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 15, 2018 Category: International Medicine & Public Health Source Type: news

Guerbet to pay $23.7m for Accurate Medical Therapeutics
Contrast agent-maker Guerbet (EPA:GBT) has inked a €19.5 million ($23.7m USD) deal to acquire Israeli medtech company Accurate Medical Therapeutics. Accurate has developed two series of microcatheters designed for embolization procedures of tumors and vascular aneurysms. The first set of catheters optimize the product’s ability to access hard-to-reach lesions and navigate tortuous vascular networks. The second range of devices incorporate holes along the terminal part of the catheter, creating a fluid blarrier to stop the reflux of embolization microspheres. The $23.7 million deal also includes additional p...
Source: Mass Device - January 12, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Catheters Imaging Mergers & Acquisitions Radiosurgery Vascular Wall Street Beat accuratemedicaltherapeutics Guerbet Source Type: news

Cancer's gene-determined 'immune landscape' dictates progression of prostate tumors
(Beth Israel Deaconess Medical Center) The field of immunotherapy -- the harnessing of patients' own immune systems to fend off cancer -- is revolutionizing cancer treatment today. However, clinical trials often show marked improvements in only small subsets of patients, suggesting that as-yet unidentified variations among tumors result in distinct paths of disease progression and response to therapy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 12, 2018 Category: Cancer & Oncology Source Type: news

Reported safety environment predicts injuries among children aged 1-6 years in specific communities - Siman-Tov M, Peleg K, Baron-Epel O.
AIM: To measure individual and environmental risk factors predicting reported child injuries. METHODS: A prospective, follow-up study was performed including 380 parents of children aged 1-6 years, living in various communities throughout Israel. P... (Source: SafetyLit)
Source: SafetyLit - January 12, 2018 Category: International Medicine & Public Health Tags: Age: Infants and Children Source Type: news

BioProtect wins FDA IDE nod for ProSpace trial
Oncology device developer BioProtect said today it won FDA investigational device exemption approval to launch a pivotal clinical study of its ProSpace balloon system designed to prevent rectal toxicity following prostate cancer radiotherapy. The ProSpace balloon system is a novel balloon spacer designed to temporarily separate the rectum from the prostate during prostate cancer radiation therapy to reduce rectal radiation exposure. The Israel-based company said it plans to launch a prospective, randomized study to explore the safety and effectiveness of the ProSpace spacer to protect the rectum and lower GI trac...
Source: Mass Device - January 10, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Food & Drug Administration (FDA) Oncology Regulatory/Compliance BioProtect Source Type: news

Check-Cap wins CE Mark for C-Scan diagnostic capsule
Check-Cap (NSDQ:CHEK) said today it won CE Mark approval in the European Union for its C-Scan ingestible sensor capsule designed for colorectal cancer screening. The Israel-based company’s C-Scan system is desgiend as an alternative to standard colon cancer screaning methods. The system uses an ingestible, ultra-low dose X-ray capsule and a wireless tracking system to return structural information on the lumen of the colon to create 2D and 3D maps. Physicians can use maps created by the system to identify pre-cancerous polyps and other abnormalities, Check-Cap said. “Achieving CE Mark approval is a si...
Source: Mass Device - January 10, 2018 Category: Medical Devices Authors: Fink Densford Tags: Diagnostics Regulatory/Compliance Check-Cap Source Type: news

Check-Cap Receives CE Mark Approval for C-Scan(R)
ISFIYA, Israel and BOSTON, Jan.10, 2018 -- (Healthcare Sales & Marketing Network) -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK) (NASDAQ: CHEKW), a clinical-stage medical diagnostics company engaged in the development... Devices, Gastroenterology, Radiology, Oncology, Regulatory Check-Cap, C-Scan, colorectal cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 10, 2018 Category: Pharmaceuticals Source Type: news

Nevro wins FDA nod for next-gen Senza II SCS
Nevro Corp. (NYSE:NVRO) said yesterday it won FDA approval for its next-generation Senza II spinal cord stimulation system. The Redwood City, Calif.-based company said the Senza II SCS system is designed to deliver HF10 therapy through a smaller footprint while maintaining the durability and performance of the current generation device. Both the next-gen device and previous versions are designed to deliver high-frequency electrical impulses of up to 10,000Hz  to the spinal cord to avoid the tingling sensation known as paresthesia that bothers some SCS patients, Nevro said. “My colleagues and I are...
Source: Mass Device - January 9, 2018 Category: Medical Devices Authors: Fink Densford Tags: Neuromodulation/Neurostimulation Pain Management Regulatory/Compliance nevro Source Type: news

Intimate partner violence prevalence, recurrence, types, and risk factors among Arab, and Jewish immigrant and nonimmigrant women of childbearing age in Israel - Daoud N, Sergienko R, Shoham-Vardi I.
This research set out to determine prevalence, recurrence, types, and risk factors for intimate partner violence (IPV) among women of childrearing age across Israel, attending to diversity in these factors by ethnicity and immigration status. The first nat... (Source: SafetyLit)
Source: SafetyLit - January 9, 2018 Category: International Medicine & Public Health Tags: Risk Factor Prevalence, Injury Occurrence Source Type: news

An Israeli model for predicting fear of terrorism based on community and individual factors - Shechory-Bitton M, Cohen-Louck K.
The purpose of the study was to suggest a model for predicting fear of terrorism using theoretical explanations that predict fear of crime. The study focused on two different levels of analysis: community and individual. The sample consisted of 507 Israeli... (Source: SafetyLit)
Source: SafetyLit - January 9, 2018 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Motus GI announces plans for $29m IPO
Motus GI said this week it intends to hold an initial public offering to raise approximately $28.8 million, according to an SEC filing. The company developed and produces the Pure-Vu cleaning system which is designed to be used with a standard colonoscope to perform intra-procedural cleaning of poorly prepared colons. Motus GI won FDA clearance for the device in September 2016. The Israel-based company said it plans to list on the NASDAQ under the ticker symbol ‘MOTS’, and said that Piper Jaffray and Oppenheimer are acting as book runners for the offering, according to the SEC filing. The company has not y...
Source: Mass Device - January 8, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Endoscopic / Arthroscopic Initial Public Offering (IPO) MOTUS GI Source Type: news

Stone age hunter-gatherers' 'paradise' discovered next to major Israeli road
Archaeologists find hundreds of hand-axes used by early humans over half a million years ago at Jaljulia, north-east of Tel AvivIsraeli archaeologists have uncovered next to one of the country ’s busiest roads the site of an extraordinarily well preserved prehistoric “paradise” used by stone age hunter-gatherers over half a million years ago, who left behind evidence of hundreds of knapped flint hand-axes.The discovery at about a five-metre depth at Jaljulia, near the town of Kfar Saba, suggests that an extinct species of early human -homo erectus– may have returned to the site repeatedly, perhaps a...
Source: Guardian Unlimited Science - January 7, 2018 Category: Science Authors: Peter Beaumont in Jerusalem Tags: Israel Archaeology Middle East and North Africa Science World news Source Type: news

Factors related to negative feelings experienced by emergency department patients and accompanying persons: an Israeli study - Landau SF, Bendalak J, Amitay G, Marcus O.
BACKGROUND: Studies on hospital violence have emphasized the importance of staff- service recipient interaction in leading to violent incidents. These incidents are the extreme result of service recipients' frustration and anger in their interaction with s... (Source: SafetyLit)
Source: SafetyLit - January 7, 2018 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Taking vitamins during pregnancy reduces risk of autism by 73%, improves baby’s overall health, new study shows
(Natural News) Taking vitamin supplements before, during, and after pregnancy may reduce the risk of autism spectrum disorder and significantly improve the baby’s overall health, according to a study published in The Journal of the American Medical Association Psychiatry. A team of researchers at the University of Haifa in Israel followed 43,500 Israeli children born between 2003... (Source: NaturalNews.com)
Source: NaturalNews.com - January 6, 2018 Category: Consumer Health News Source Type: news

Traumatic events exposure and psychological trauma in children victims of war in the Gaza Strip - Manzanero AL, Crespo M, Bar ón S, Scott T, El-Astal S, Hemaid F.
The objective was twofold: (a) to identify the prevalence... (Source: SafetyLit)
Source: SafetyLit - January 6, 2018 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

First discover the disorder and then find the patients
(Bielefeld University) Biochemists of Bielefeld University have confirmed the cause of initially unclear symptoms of patients in Israel. Their studies reveal that the patients suffer from a disorder called 'MPS III-E.' It was discovered by the Bielefeld researchers in 2012. However, until now there were no known patients. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 5, 2018 Category: International Medicine & Public Health Source Type: news

Folic Acid, Multivitamins During Pregnancy May Cut ASD Risk
(MedPage Today) -- Israeli researchers caution that'the effect of confounding was notable'(Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - January 4, 2018 Category: Psychiatry Source Type: news

Prenatal Vitamins Tied to Lower Autism Risk
Kids were less likely to be diagnosed with autism if their moms took supplements before pregnancy and while they were expecting, according to a study of just over 45,000 Israeli children. (Source: WebMD Health)
Source: WebMD Health - January 3, 2018 Category: Consumer Health News Source Type: news

Taking vitamins before pregnancy cuts risk of autism
A new study from Haifa University in Israel found that taking folic acid and multivitamins before and during pregnancy cuts the risk of a child developing autism by 73 percent. (Source: the Mail online | Health)
Source: the Mail online | Health - January 3, 2018 Category: Consumer Health News Source Type: news

PharmaMar Signs a Commercialization and Distribution License Agreement for Aplidin(R) (plitidepsin) With Megapharm in Israel
MADRID, January 2, 2018 -- (Healthcare Sales & Marketing Network) --PharmaMar (MCE: PHM) has announced today a commercialization and distribution license agreement with Megapharm Ltd. for the marine-derived anticancer drug Aplidin® (plitidepsin) in Is... Biopharmaceuticals, Oncology, Licensing, Distribution PharmaMar , Megapharm, Aplidin, plitidepsin (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 2, 2018 Category: Pharmaceuticals Source Type: news

PharmaMar signs a license agreement for Aplidin ® with Megapharm in Israel
(Pharmamar) PharmaMar (MSE:PHM) has announced today a commercialization and distribution license agreement with Megapharm Ltd. for the marine-derived anticancer drug Aplidin ® (plitidepsin) in Israel and the territory known as the Palestinian Authority. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 2, 2018 Category: International Medicine & Public Health Source Type: news

Israeli EMS Innovations
This article highlights those advances and innovations.   A Coordinated Effort Most Israelis serve in the military for a mandatory period of time, and then continue to serve at least once a year in reserve duty. Reserve duty can include as many as five different deployments per year, depending on a person’s rank and position. Because of this, there’s ongoing crossover between the military and civilian arenas. Often, what a person learns in one area is applicable in both. (Source: JEMS Operations)
Source: JEMS Operations - January 1, 2018 Category: Emergency Medicine Authors: Dov Maisel, EMT-P Tags: Operations Equipment & Gear Source Type: news

RedHill teams with Mayo Clinic, MD Anderson on new cancer trial
Tel-Aviv, Israel-based RedHill Biopharma (Nasdaq: RDHL) – which is continuing to build up its U.S. commercial operations based in Raleigh – is teaming with the Mayo Clinic and The University of Texas MD Anderson Cancer Center on a new cancer trial. The new Phase IIa study is for YELIVA – a product candidate RedHill acquired from Apogee Biotechnolo gy back in 2015 – for the treatment of cholangiocarcinoma, or bile duct cancer. It will enroll patients at Mayo Clinic campuses in both Arizona… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 28, 2017 Category: Pharmaceuticals Authors: Jennifer Henderson Source Type: news

Integrity Applications Signs Distribution Agreement for Its GlucoTrack(R) Non-Invasive Glucose Monitoring Device in the Netherlands
Contract Represents Important First Step in European Re-Launch WILMINGTON, Del. and ASHDOD, Israel, Dec. 28, 2017 -- (Healthcare Sales & Marketing Network) -- Integrity Applications, Inc. ("Integrity") (OTCQB: IGAP), innovator of GlucoTrack&r... Devices, Endocrinology, Distribution Integrity Applications, MediReva, GlucoTrack (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 28, 2017 Category: Pharmaceuticals Source Type: news

Leaving the House Linked to Longevity in Older Adults Leaving the House Linked to Longevity in Older Adults
and the effect is independent of medical problems or mobility issues, according to new research from Israel.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 28, 2017 Category: Consumer Health News Tags: Internal Medicine News Source Type: news

Protalix BioTherapeutics’ PRX-102 Granted Orphan Drug Designation by the European Commission
CARMIEL, Israel, Dec. 27, 2017 -- (Healthcare Sales & Marketing Network) -- Protalix BioTherapeutics, Inc. (NYSE American:PLX) (TASE:PLX), a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins expr... Biopharmaceuticals, Regulatory Protalix BioTherapeutics, ProCellEx, pegunigalsidase alfa, Fabry disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 27, 2017 Category: Pharmaceuticals Source Type: news

BiondVax Plans Phase 3 Clinical Trial Following Receipt of Scientific Advice from the European Medicines Agency (EMA)
NESS ZIONA, Israel, Dec. 27, 2017 -- (Healthcare Sales & Marketing Network) -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV, TASE: BVXV) announced today that the European Medicines Agency (EMA)'s Committee for Medicinal Products for Human Use (CHMP) review... Biopharmaceuticals, Regulatory BiondVax Pharmaceuticals, flu vaccine, universal flu vaccine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 27, 2017 Category: Pharmaceuticals Source Type: news

‘ Nobody Thought It Would Come to This ’ : Drug Maker Teva Faces a Crisis
The move by Israel ’ s corporate version of a celebrity to lay off 14,000 workers was greeted with outrage, a nationwide strike and much disappointment. (Source: NYT Health)
Source: NYT Health - December 27, 2017 Category: Consumer Health News Authors: DAVID SEGAL and ISABEL KERSHNER Tags: Layoffs and Job Reductions Generic Brands and Products Teva Pharmaceutical Industries Ltd Israel Jerusalem (Israel) Drugs (Pharmaceuticals) Labor and Jobs Source Type: news

Iran Confirms Upholding Death Sentence for Academic Over Spying Iran Confirms Upholding Death Sentence for Academic Over Spying
Iran's Supreme Court has upheld a death sentence against a Sweden-based Iranian academic convicted of spying for Israel, the Tehran prosecutor was quoted as saying on Monday, confirming reports by Amnesty International and his family.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 27, 2017 Category: Consumer Health News Tags: Family Medicine/Primary Care News Source Type: news

Israel's Super-Pharm in Talks to Buy Teva Pharm Plant Israel's Super-Pharm in Talks to Buy Teva Pharm Plant
Israel's largest pharmacy chain Super-Pharm (Israel) Ltd is in talks to acquire Teva Pharmaceutical Industries'plant in the coastal city of Ashdod, a source familiar with the matter said on Sunday, confirming media reports.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 27, 2017 Category: Consumer Health News Tags: Family Medicine/Primary Care News Source Type: news

Leaving the house linked to longevity in older adults
(Reuters Health) - For older people, getting out of the house regularly may contribute to a longer life - and the effect is independent of medical problems or mobility issues, according to new research from Israel. (Source: Reuters: Health)
Source: Reuters: Health - December 26, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

New Research Probes the Criminal Mind
TUESDAY, Dec. 26, 2017 -- Are brain lesions linked to criminal behavior? That's the suggestion of a new study by researchers at Beth Israel Deaconess Medical Center in Boston. Ever since the 1966 University of Texas Tower mass shooting, which left... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 26, 2017 Category: General Medicine Source Type: news

Fatal overdoses of opioids in Israel 2005-2014 - Feingold D, Goldberger N, Haklai Z, Lev-Ran S.
AIMS: To explore previously unreported rates and trends in opioid-related mortality in Israel, 2005-2014. METHODS: Data was obtained from the national database on causes of death. Drug poisoning deaths were divided into opioid-related deaths and de... (Source: SafetyLit)
Source: SafetyLit - December 25, 2017 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Israel's Super-Pharm in talks to buy Teva Pharm plant: source
TEL AVIV (Reuters) - Israel's largest pharmacy chain Super-Pharm (Israel) Ltd is in talks to acquire Teva Pharmaceutical Industries' plant in the coastal city of Ashdod, a source familiar with the matter said on Sunday, confirming media reports. (Source: Reuters: Health)
Source: Reuters: Health - December 24, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Israel's Super-Pharm in talks to buy Teva Pharm plant: media
TEL AVIV (Reuters) - Israel's largest pharmacy chain Super-Pharm (Israel) Ltd is in talks to acquire Teva Pharmaceutical Industries' plant in the coastal city of Ashdod, Israeli media said on Sunday. (Source: Reuters: Health)
Source: Reuters: Health - December 24, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Lahey, Beth Israel mega-merger gets lots of praise, some criticism
A proposed mega-merger involving Lahey Health, Beth Israel Deaconess Medical Center and three community hospitals has received support from an array of community groups, local businesses and state officials, despite concerns voiced by some state groups. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 21, 2017 Category: Pharmaceuticals Authors: Jessica Bartlett Source Type: news

ParMedQuest invests in helparound, will co-market HIV, Hepatitis C management app
Healthcare management company PharMedQuest announced last week that it has made a strategic investment in helparound, an Israeli company which makes an app that supports and connects patients with chronic conditions. The companies have also made an agreement to co-market the mobile app, called ACE, to speciality pharmaceutical companies and patient hubs.   (Source: mobihealthnews)
Source: mobihealthnews - December 20, 2017 Category: Information Technology Source Type: news

Boston Hospital Brings Holiday Cheer To Families In NICU
BOSTON (CBS) – Home for the holidays is just not a possibility for some children and their families, but one Boston hospital is bringing the holidays to them. At the Neonatal Intensive Care Unit (NICU) at the Beth Israel Deaconess Medical Center, it was a day to make memories and for the parents of their youngest patients, a much appreciated break. Little Rebecca has been in the NICU for almost two months. So have the twins Kaden and Kadance, who were not even three pounds when they were born. It’s been even longer than that for Kevin. “We evacuated from Hurricane Irma,” says Kevin’s mother ...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - December 19, 2017 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health Local News Syndicated Local Beth Israel Deaconess Medical Center Lisa Hughes NICU Source Type: news

Teva exits Mass. as Cambridge site falls victim to restructuring
The Israel-based drugmaker said last week that it was cutting around 14,000 jobs across the globe and closing "a significant number" of offices. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - December 19, 2017 Category: American Health Authors: Max Stendahl Source Type: news

Teva exits Mass. as Cambridge site falls victim to restructuring
The Israel-based drugmaker said last week that it was cutting around 14,000 jobs across the globe and closing "a significant number" of offices. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 19, 2017 Category: Biotechnology Authors: Max Stendahl Source Type: news

Report: Protest over Teva layoffs shuts down Israel ’ s airport, banks
Israel’s public-sector labor union staged a strike yesterday to protest Teva Pharmaceuticals‘ (NYSE:TEVA) move to cut more than 25% of its global workforce in an effort to restructure the company. Teva is one of Israel’s largest companies and its decision to close an Israel-based manufacturing site and slash jobs has angered groups in Israel, who point the blame at debts that Teva has acquired abroad. Get the full story at our sister site, Drug Delivery Business News. The post Report: Protest over Teva layoffs shuts down Israel’s airport, banks appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - December 18, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Pharmaceuticals Wall Street Beat Teva Pharmaceuticals Source Type: news